ebomi
Colour theme
Sign in
Insider · CIK 0001377202

Sharp Shalini

CIK 0001377202 Name as filed on the most recent filing

Filed as Sharp Shalini (43)

69 transaction lines · from 43 filings · filed 2007-03-14 to 2024-05-21 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

69 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2024-05-17 Neurocrine Biosciences Inc
NBIX 		S, Open-market sale 1,106 disposed 141.90 156,943.39 Form 4, filing 0000914475-24-000138
2020-10-14 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 375 disposed 87.99 32,996.25 Form 4, filing 0001209191-20-055172
2020-08-17 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 7,188 disposed 88.38 635,275.44 Form 4, filing 0001209191-20-047455
2020-08-17 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 3,669 disposed 88.38 324,266.22 Form 4, filing 0001209191-20-047455
2020-08-17 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 2,560 disposed 88.54 226,662.40 Form 4, filing 0001209191-20-047455
2020-08-17 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 500 disposed 88.38 44,190.00 Form 4, filing 0001209191-20-047455
2020-08-17 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 461 disposed 88.24 40,678.64 Form 4, filing 0001209191-20-047455
2020-06-04 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 2,564 disposed 74.01 189,761.64 Form 4, filing 0001209191-20-034710
2020-06-03 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 10,234 disposed 74.23 759,669.82 Form 4, filing 0001209191-20-034710
2020-05-19 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 3,907 disposed 73.32 286,461.24 Form 4, filing 0001209191-20-031054
2020-05-19 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 3,221 disposed 73.32 236,163.72 Form 4, filing 0001209191-20-031054
2020-05-18 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 19,593 disposed 73.34 1,436,950.62 Form 4, filing 0001209191-20-031054
2020-05-18 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 2,392 disposed 73.29 175,309.68 Form 4, filing 0001209191-20-031054
2019-03-18 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 14,800 disposed 70.00 1,036,000.00 Form 4, filing 0001209191-19-025094
2019-03-18 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 14,800 disposed 70.00 1,036,000.00 Form 4, filing 0001209191-19-020568
2019-03-05 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 1,012 disposed 65.52 66,306.24 Form 4, filing 0001209191-19-025079
2018-09-25 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 6,700 disposed 90.07 603,469.00 Form 4, filing 0001209191-18-052438
2018-06-07 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 6,700 disposed 80.07 536,455.60 Form 4, filing 0001209191-18-036501
2018-05-30 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 13,000 disposed 70.17 912,171.00 Form 4, filing 0001209191-18-034281
2017-03-02 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 12,000 disposed 90.10 1,081,176.00 Form 4, filing 0001209191-17-017612
2017-02-27 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 12,000 disposed 80.14 961,680.00 Form 4, filing 0001209191-17-015378
2016-11-09 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 13,600 disposed 70.06 952,816.00 Form 4, filing 0001562180-16-003444
2016-11-09 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 3,895 disposed 71.68 279,193.60 Form 4, filing 0001562180-16-003444
2016-11-09 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 3,205 disposed 72.81 233,356.05 Form 4, filing 0001562180-16-003444
2016-11-09 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 2,600 disposed 73.65 191,490.00 Form 4, filing 0001562180-16-003444
2016-11-09 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 700 disposed 74.34 52,038.00 Form 4, filing 0001562180-16-003444
2016-10-19 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 6,932 disposed 61.71 427,773.72 Form 4, filing 0001562180-16-003255
2016-10-19 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 5,068 disposed 60.98 309,046.64 Form 4, filing 0001562180-16-003255
2015-12-10 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 6,723 disposed 102.16 686,821.68 Form 4, filing 0001562180-15-001071
2015-12-10 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 5,277 disposed 101.03 533,135.31 Form 4, filing 0001562180-15-001071
2015-07-20 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 1,954 disposed 132.47 258,846.38 Form 4, filing 0001562180-15-000584
2015-07-20 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 1,412 disposed 131.56 185,762.72 Form 4, filing 0001562180-15-000584
2015-07-20 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 488 disposed 130.99 63,923.12 Form 4, filing 0001562180-15-000584
2015-07-20 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 1,954 disposed 132.47 258,846.38 Form 4, filing 0001562180-15-000585
2015-07-20 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 1,412 disposed 131.56 185,762.72 Form 4, filing 0001562180-15-000585
2015-07-20 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 488 disposed 130.99 63,923.12 Form 4, filing 0001562180-15-000585
2015-06-18 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 2,651 disposed 95.95 254,363.45 Form 4, filing 0001562180-15-000508
2015-06-18 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 1,349 disposed 96.35 129,976.15 Form 4, filing 0001562180-15-000508
2015-05-18 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 4,000 disposed 79.43 317,720.00 Form 4, filing 0001562180-15-000386
2015-04-20 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 3,000 disposed 62.59 187,770.00 Form 4, filing 0001562180-15-000301
2015-04-20 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 1,000 disposed 61.14 61,140.00 Form 4, filing 0001562180-15-000301
2015-03-18 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 4,000 disposed 61.45 245,800.00 Form 4, filing 0001182489-15-000421
2015-02-18 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 3,704 disposed 53.93 199,739.31 Form 4, filing 0001182489-15-000352
2015-02-18 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 296 disposed 54.72 16,196.17 Form 4, filing 0001182489-15-000352
2015-01-20 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 4,000 disposed 51.24 204,957.20 Form 4, filing 0001182489-15-000072
2014-12-18 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 4,000 disposed 44.82 179,289.60 Form 4, filing 0001182489-14-001234
2014-11-20 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 4,000 disposed 44.07 176,281.20 Form 4, filing 0001182489-14-001129
2014-10-20 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 4,000 disposed 46.02 184,080.00 Form 4, filing 0001182489-14-001039
2014-09-18 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 4,000 disposed 56.00 224,000.00 Form 4, filing 0001182489-14-001001
2014-08-18 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 4,000 disposed 53.97 215,880.00 Form 4, filing 0001182489-14-000909

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 3
  • Open-market sale 66
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Sharp Shalini, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001377202

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.